338 related articles for article (PubMed ID: 18413317)
1. Control of extended-spectrum {beta}-lactamase-producing Klebsiella pneumoniae using a computer-assisted management program to restrict third-generation cephalosporin use.
Kim JY; Sohn JW; Park DW; Yoon YK; Kim YM; Kim MJ
J Antimicrob Chemother; 2008 Aug; 62(2):416-21. PubMed ID: 18413317
[TBL] [Abstract][Full Text] [Related]
2. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS
J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919
[TBL] [Abstract][Full Text] [Related]
3. Comment on: Control of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae using a computer-assisted management program to restrict third-generation cephalosporin use.
Huttner B; Pittet D; Harbarth S
J Antimicrob Chemother; 2008 Nov; 62(5):1165; author reply 1165-6. PubMed ID: 18658195
[No Abstract] [Full Text] [Related]
4. Influence of third-generation cephalosporin utilization on the occurrence of ESBL-positive Klebsiella pneumoniae strains.
Urbánek K; Kolár M; Lovecková Y; Strojil J; Santavá L
J Clin Pharm Ther; 2007 Aug; 32(4):403-8. PubMed ID: 17635342
[TBL] [Abstract][Full Text] [Related]
5. Cross-class resistance to non-beta-lactam antimicrobials in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.
Procop GW; Tuohy MJ; Wilson DA; Williams D; Hadziyannis E; Hall GS
Am J Clin Pathol; 2003 Aug; 120(2):265-7. PubMed ID: 12931557
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibility pattern and prevalence of extended spectrum beta-lactamase (ESBLs) producing strains of Klebsiella pneumoniae from a major hospital in New Delhi.
Grover SS; Sharma M; Pasha ST; Singh G; Lal S
J Commun Dis; 2004 Mar; 36(1):17-26. PubMed ID: 16295682
[TBL] [Abstract][Full Text] [Related]
7. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)].
Zarakolu P; Hasçelik G; Unal S
Mikrobiyol Bul; 2006 Jul; 40(3):147-54. PubMed ID: 17001842
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, antibiotic susceptibility pattern and production of extended-spectrum beta-lactamases amongst clinical isolates of Klebsiella pneumoniae at Armed Forces Hospital in Saudi Arabia.
Ahmad S; Al-Juaid NF; Alenzi FQ; Mattar EH; Bakheet Oel-S
J Coll Physicians Surg Pak; 2009 Apr; 19(4):264-5. PubMed ID: 19356348
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic and genotypic detection of ESBL mediated cephalosporin resistance in Klebsiella pneumoniae: emergence of high resistance against cefepime, the fourth generation cephalosporin.
Grover SS; Sharma M; Chattopadhya D; Kapoor H; Pasha ST; Singh G
J Infect; 2006 Oct; 53(4):279-88. PubMed ID: 16488476
[TBL] [Abstract][Full Text] [Related]
10. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates.
Al-Zarouni M; Senok A; Rashid F; Al-Jesmi SM; Panigrahi D
Med Princ Pract; 2008; 17(1):32-6. PubMed ID: 18059098
[TBL] [Abstract][Full Text] [Related]
12. Radical reduction of cephalosporin use at a tertiary hospital after educational antibiotic intervention during an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.
Tängdén T; Eriksson BM; Melhus A; Svennblad B; Cars O
J Antimicrob Chemother; 2011 May; 66(5):1161-7. PubMed ID: 21393158
[TBL] [Abstract][Full Text] [Related]
13. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae hospital acquired bacteremia. Risk factors and clinical outcome.
Panhotra BR; Saxena AK; Al-Ghamdi AM
Saudi Med J; 2004 Dec; 25(12):1871-6. PubMed ID: 15711657
[TBL] [Abstract][Full Text] [Related]
14. [Evolution of susceptibility to antibiotics of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumanii, in a University Hospital Center of Beirut between 2005 and 2009].
Hamouche E; Sarkis DK
Pathol Biol (Paris); 2012 Jun; 60(3):e15-20. PubMed ID: 21719212
[TBL] [Abstract][Full Text] [Related]
15. [Extended-spectrum beta-lactamase production and antimicrobial resistance patterns of Klebsiella pneumoniae strains isolated from nosocomial bacteremic patients: evaluation of the results of 2001-2005 period].
Taşbakan MI; Pullukçu H; Sipahi OR; Aydemir S; Arda B; Yamazhan T; Tunger A; Ulusoy S
Mikrobiyol Bul; 2008 Jan; 42(1):1-7. PubMed ID: 18444557
[TBL] [Abstract][Full Text] [Related]
16. Clonal spread of both oxyimino-cephalosporin- and cefoxitin-resistant Klebsiella pneumoniae isolates co-producing SHV-2a and DHA-1 beta-lactamase at a burns intensive care unit.
Song W; Lee KM; Kim HS; Kim JS; Kim J; Jeong SH; Roh KH
Int J Antimicrob Agents; 2006 Dec; 28(6):520-4. PubMed ID: 17095195
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
[TBL] [Abstract][Full Text] [Related]
18. Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae A case-control study.
Mosqueda-Gómez JL; Montaño-Loza A; Rolón AL; Cervantes C; Bobadilla-del-Valle JM; Silva-Sánchez J; Garza-Ramos U; Villasís-Keever A; Galindo-Fraga A; Palacios GM; Ponce-de-León A; Sifuentes-Osornio J
Int J Infect Dis; 2008 Nov; 12(6):653-9. PubMed ID: 18511321
[TBL] [Abstract][Full Text] [Related]
19. [Short communication: Extended-spectrum beta-lactamase production in Klebsiella pneumoniae strains isolated from blood cultures and their antibiotic susceptibilities].
Işik F; Arslan U; Tuncer I
Mikrobiyol Bul; 2008 Jan; 42(1):131-6. PubMed ID: 18444571
[TBL] [Abstract][Full Text] [Related]
20. Differences in the changes in resistance patterns to third- and fourth-generation cephalosporins and piperacillin/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospital.
Petrikkos G; Markogiannakis A; Papaparaskevas J; Daikos GL; Stefanakos G; Zissis NP; Avlamis A
Int J Antimicrob Agents; 2007 Jan; 29(1):34-8. PubMed ID: 17189092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
